Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force

1. Averna, M.
2. Banach, M.
3. Bruckert, E.
4. Drexel, H.
5. Farnier, M.
6. Gaita, D.
7. Magni, P.
8. März, W.
9. Masana, L.
10. Mello e Silva, A.
11. Reiner, Z.
12. Ros, E.
13. Vrablik, M.
14. Zambon, A.
15. Zamorano, J.L.
16. Stock, J.K.
17. Tokgözoğlu, L.S.
18. Catapano, A.L.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.ATHEROSCLEROSIS.2021.03.039 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus